Locoregional Failure Rates Are Low After Mastectomy in a Modern Cohort of Patients With T1-T2 Tumors With 1-3 Pathologically Involved Lymph Nodes

被引:0
|
作者
Bazan, J. G. [1 ]
Majithia, L. [2 ]
Quick, A. M. [2 ]
Terando, A. M. [2 ]
Agnese, D. M. [2 ]
Mrozek, E. [2 ]
Farrar, W. [2 ]
White, J. R. [2 ]
机构
[1] Ohio State Univ, Wexner Med Ctr, Columbus, OH 43210 USA
[2] Ohio State Univ, Columbus, OH 43210 USA
关键词
D O I
10.1016/j.ijrobp.2015.07.538
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1165
引用
收藏
页码:S223 / S223
页数:1
相关论文
共 50 条
  • [1] Locoregional failure rates do not vary by breast cancer subtype after mastectomy in a modern cohort of patients with T1-2 tumors with 1-3 pathologically involved lymph nodes
    Bazan, J. G.
    Majithia, L.
    Quick, A. M.
    Terando, A. M.
    Agnese, D.
    Mrozek, E.
    Farrar, W.
    White, J. R.
    [J]. CANCER RESEARCH, 2016, 76
  • [2] Locoregional failure rates do not vary by breast cancer subtype after mastectomy in a modern cohort of patients with T1-2 tumors with 1-3 pathologically involved lymph nodes
    Bazan, J. G.
    Majithia, L.
    Quick, A. M.
    Terando, A. M.
    Agnese, D.
    Mrozek, E.
    Farrar, W.
    White, J. R.
    [J]. CANCER RESEARCH, 2016, 76
  • [3] Impact of Molecular Subtype on Locoregional Recurrence in Mastectomy Patients with T1-T2 Breast Cancer and 1-3 Positive Lymph Nodes
    Moo, Tracy-Ann
    McMillan, Robert
    Lee, Michele
    Stempel, Michelle
    Ho, Alice
    Patil, Sujata
    El-Tamer, Mahmoud
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (05) : 1569 - 1574
  • [4] Post-Mastectomy Radiotherapy for Breast Cancer Patients with T1-T2 and 1-3 Positive Lymph Nodes: a Meta-Analysis
    Li, Yaming
    Moran, Meena S.
    Huo, Qiang
    Yang, Qifeng
    Haffty, Bruce G.
    [J]. PLOS ONE, 2013, 8 (12):
  • [5] Whether adjuvant radiotherapy is desired for postmastectomy patients with T1-T2 tumors and 1-3 positive axillary lymph nodes who received modern systemic therapy?
    Lai, Shih-Fan
    Huang, Chiun-Sheng
    Kuo, Sung-Hsin
    [J]. TRANSLATIONAL CANCER RESEARCH, 2019, 8 : S110 - S114
  • [6] Impact of Molecular Subtype on Locoregional Recurrence in Mastectomy Patients with T1-2 Breast Cancer and 1-3 Positive Lymph Nodes
    Moo, T.
    McMillan, R.
    Lee, M.
    Stempel, M.
    Ho, A. Y.
    Patil, S.
    El-Tamer, M.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2013, 20 : S43 - S43
  • [7] Locoregional Recurrence after Mastectomy in Breast Cancer Patients with 1-3 Positive Lymph Nodes Treated with Modern Systemic Therapy
    Tendulkar, R. D.
    Rehman, S.
    Shukla, M.
    Reddy, C. A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S91 - S92
  • [8] Selection Criteria for Postmastectomy Radiotherapy in T1-T2 Tumors with 1 to 3 Positive Lymph Nodes
    Moo, Tracy Ann
    McMillan, Robert
    Lee, Michele
    Stempel, Michelle
    Patil, Sujata
    Ho, Alice
    El-Tamer, Mahmoud
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (10) : 3169 - 3174
  • [9] Improved Survival with Postmastectomy Radiation Therapy in Premenopausal Patients With T1-T2 Breast Cancer and 1-3 Positive Lymph Nodes
    Mu, Yijia
    Diego, Emilia
    McAuliffe, Priscilla
    McGuire, Kandace
    Soran, Atilla
    Bonaventura, Marguerite
    Johnson, Ronald
    Beriwal, Sushil
    Ahrendt, Gretchen
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : 112 - 113
  • [10] Locoregional failure rates in patients with involved axillary nodes after mastectomy and systemic therapy
    Recht, A
    [J]. SEMINARS IN RADIATION ONCOLOGY, 1999, 9 (03) : 223 - 229